Aurora Cannabis (TSE:ACB - Get Free Report) is scheduled to be releasing its earnings data before the market opens on Wednesday, November 6th. Analysts expect Aurora Cannabis to post earnings of C($0.14) per share for the quarter.
Aurora Cannabis (TSE:ACB - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported C($0.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of C($0.48) by C$0.32. Aurora Cannabis had a negative return on equity of 6.13% and a negative net margin of 11.53%. The firm had revenue of C$92.04 million for the quarter, compared to analyst estimates of C$76.70 million.
Aurora Cannabis Stock Performance
Aurora Cannabis stock traded down C$0.34 during mid-day trading on Wednesday, reaching C$7.88. 738,234 shares of the company were exchanged, compared to its average volume of 1,077,250. The firm has a market cap of C$430.72 million, a PE ratio of -13.13 and a beta of 2.71. The company has a debt-to-equity ratio of 16.95, a quick ratio of 2.48 and a current ratio of 3.76. The firm's 50-day simple moving average is C$7.84 and its two-hundred day simple moving average is C$8.24. Aurora Cannabis has a twelve month low of C$3.84 and a twelve month high of C$12.85.
Insider Activity at Aurora Cannabis
In other news, Senior Officer Andre Jerome sold 7,712 shares of the business's stock in a transaction dated Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
See Also
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
